OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
Marijn Thijssen, Timothy Devos, Hanieh-Sadat Ejtahed, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1733-1733
Open Access | Times Cited: 17
Marijn Thijssen, Timothy Devos, Hanieh-Sadat Ejtahed, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1733-1733
Open Access | Times Cited: 17
Showing 17 citing articles:
Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case–control study in an Arab Gulf country
Abdullah Alguwaihes, Shaun Sabico, Rana Hasanato, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 5, pp. 1415-1422
Open Access | Times Cited: 64
Abdullah Alguwaihes, Shaun Sabico, Rana Hasanato, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 5, pp. 1415-1422
Open Access | Times Cited: 64
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
American Journal of Public Health (2021) Vol. 111, Iss. 6, pp. 1086-1094
Open Access | Times Cited: 62
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
American Journal of Public Health (2021) Vol. 111, Iss. 6, pp. 1086-1094
Open Access | Times Cited: 62
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
Tharmala Tharmalingam, Xiaobing Han, Ashley Wozniak, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 24
Tharmala Tharmalingam, Xiaobing Han, Ashley Wozniak, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 24
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part II
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
American Journal of Public Health (2021) Vol. 111, Iss. 7, pp. 1267-1272
Open Access | Times Cited: 23
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
American Journal of Public Health (2021) Vol. 111, Iss. 7, pp. 1267-1272
Open Access | Times Cited: 23
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity
Zeynab Rahni, Seyed Masoud Hosseini, Shabnam Shahrokh, et al.
Virus Research (2023) Vol. 336, pp. 199214-199214
Open Access | Times Cited: 9
Zeynab Rahni, Seyed Masoud Hosseini, Shabnam Shahrokh, et al.
Virus Research (2023) Vol. 336, pp. 199214-199214
Open Access | Times Cited: 9
Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis
Mohammadreza Pourkarim, Shahnaz Nayebzadeh, Seyed Moayed Alavian, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 626-626
Open Access | Times Cited: 13
Mohammadreza Pourkarim, Shahnaz Nayebzadeh, Seyed Moayed Alavian, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 626-626
Open Access | Times Cited: 13
Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients
Mobin Makhmalbaf, Seyed Masoud Hosseini, Hamid Asadzadeh Aghdaei, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Mobin Makhmalbaf, Seyed Masoud Hosseini, Hamid Asadzadeh Aghdaei, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Contemporary narrative review of treatment options for COVID ‐19
Lianhan Shang, David Chien Lye, Bin Cao
Respirology (2021) Vol. 26, Iss. 8, pp. 745-767
Open Access | Times Cited: 12
Lianhan Shang, David Chien Lye, Bin Cao
Respirology (2021) Vol. 26, Iss. 8, pp. 745-767
Open Access | Times Cited: 12
Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives
Cassiano Martin Batista, Leonardo Foti
International Immunopharmacology (2021) Vol. 99, pp. 108036-108036
Open Access | Times Cited: 12
Cassiano Martin Batista, Leonardo Foti
International Immunopharmacology (2021) Vol. 99, pp. 108036-108036
Open Access | Times Cited: 12
Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins
Raymond M Slay, Rachel Cook, Katherine Hendricks, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_3, pp. S441-S450
Open Access | Times Cited: 8
Raymond M Slay, Rachel Cook, Katherine Hendricks, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_3, pp. S441-S450
Open Access | Times Cited: 8
Characterization of the Human Blood Virome in Iranian Multiple Transfused Patients
Marijn Thijssen, Gholamreza Khamisipour, Mohammad Maleki, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 4
Marijn Thijssen, Gholamreza Khamisipour, Mohammad Maleki, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 4
A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity
Xiangyu Yao, Zhichao Zhang, Qingmin Mei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Xiangyu Yao, Zhichao Zhang, Qingmin Mei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Antibody Therapy for COVID-19: Categories, Pros, and Cons
Hadi Zare Marzouni, Marjan Rahbar, Nazanin Sadat Seddighi, et al.
Viral Immunology (2022) Vol. 35, Iss. 8, pp. 517-528
Closed Access | Times Cited: 1
Hadi Zare Marzouni, Marjan Rahbar, Nazanin Sadat Seddighi, et al.
Viral Immunology (2022) Vol. 35, Iss. 8, pp. 517-528
Closed Access | Times Cited: 1
Eficacia y seguridad de la administración de plasma de convaleciente en pacientes con COVID-19
Priscila Edith Escobedo-Sánchez, Ibis De la Cruz-Hernández, Meztli Ramos-García, et al.
Medicina Clínica (2023) Vol. 161, Iss. 8, pp. 323-329
Open Access
Priscila Edith Escobedo-Sánchez, Ibis De la Cruz-Hernández, Meztli Ramos-García, et al.
Medicina Clínica (2023) Vol. 161, Iss. 8, pp. 323-329
Open Access
Efficacy and safety of convalescent plasma administration in patients with COVID-19
Priscila Edith Escobedo-Sánchez, Ibis de la Cruz-Hernández, Meztli Ramos-García, et al.
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 8, pp. 323-329
Closed Access
Priscila Edith Escobedo-Sánchez, Ibis de la Cruz-Hernández, Meztli Ramos-García, et al.
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 8, pp. 323-329
Closed Access
A randomized open-label clinical trial to evaluate convalescent plasma compared to conventional standard care management for SARS-CoV-2 (COVID-19) in hospitalized patients in the Dominican Republic
Angiolina Camilo, Socrates Sosa, Dolores Mejía, et al.
International Journal of Blood Transfusion and Immunohematology (2022) Vol. 12, Iss. 1, pp. 1-13
Open Access
Angiolina Camilo, Socrates Sosa, Dolores Mejía, et al.
International Journal of Blood Transfusion and Immunohematology (2022) Vol. 12, Iss. 1, pp. 1-13
Open Access
Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program
Mahmoud Reza Pourkarim
Hepatitis Monthly (2022) Vol. 22, Iss. 1
Open Access
Mahmoud Reza Pourkarim
Hepatitis Monthly (2022) Vol. 22, Iss. 1
Open Access
